Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapy.
about
Prevention and treatment of bone fragility in cancer patientLifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an updateSIMBOSPROST: Prevalence of metabolic syndrome and osteoporosis in prostate cancer patients treated with radiotherapy and androgen deprivation therapy: A multicentre, cross-sectional study.The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation.Health status of older cancer survivors-results of the PolSenior study.Osteoporosis-Related Health Behaviors in Men With Prostate Cancer and Survivors: Exploring Osteoporosis Knowledge, Health Beliefs, and Self-Efficacy.
P2860
Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Prevalence of osteoporosis in ...... androgen deprivation therapy.
@en
type
label
Prevalence of osteoporosis in ...... androgen deprivation therapy.
@en
prefLabel
Prevalence of osteoporosis in ...... androgen deprivation therapy.
@en
P2860
P50
P1433
P1476
Prevalence of osteoporosis in ...... n androgen deprivation therapy
@en
P2093
Olivia R L Wright
P2860
P2888
P304
P356
10.1007/S12020-015-0536-7
P577
2015-01-31T00:00:00Z